Attached files
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
Amendment No. 1
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 2, 2011
Cynosure, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware | 000-51623 | 04-3125110 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
5 Carlisle Road, Westford, MA | 01886 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (978) 256-4200
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Explanatory Note
Cynosure, Inc., a Delaware corporation (Cynosure), hereby amends its Current Report on Form 8-K which was initially filed by Cynosure on February 3, 2011, to include the financial statements required by Item 9.01 hereof. These financial statements were intentionally omitted from the initial Current Report on Form 8-K because Cynosure did not have all of the necessary information to file such financial statements on the initial filing date. These financial statements are filed as Exhibits 99.2, 99.3 and 99.4 to this amendment on this Current Report on Form 8-K.
Item 9.01. | Financial Statements and Exhibits |
(a) | Financial Statements of Business Acquired |
The audited financial statements of Elemé Medical Inc. (Elemé Medical) as of December 31, 2009 and 2008 and for each of the three years in the period ended December 31, 2009, are filed herewith and attached as Exhibit 99.2.
The unaudited interim financial statements of Elemé Medical as of and for the nine months ended September 30, 2010 and 2009, are filed herewith and attached as Exhibit 99.3.
(b) | Pro Forma Financial Information |
The unaudited pro forma financial statements of Cynosure as of and for the nine months ended September 30, 2010, and for the year ended December 31, 2009, are filed herewith and attached as Exhibit 99.4.
(d) | Exhibits |
See the exhibit index attached hereto.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CYNOSURE, INC. | ||||||
Date: April 15, 2011 | By: | /s/ Timothy W. Baker | ||||
Timothy W. Baker | ||||||
Executive Vice President and Chief | ||||||
Financial Officer |
EXHIBIT INDEX
Exhibit No. |
Description | |
23.1 | Consent of Ernst & Young LLP | |
99.2 | Audited financial statements of Elemé Medical Inc. as of December 31, 2009 and 2008 and for each of the three years in the period ended December 31, 2009 | |
99.3 | Unaudited interim financial statements of Elemé Medical Inc. as of and for the nine months ended September 30, 2010 and 2009 | |
99.4 | Unaudited pro forma financial statements of Cynosure, Inc. as of and for the nine months ended September 30, 2010 and for the year ended December 31, 2009 |